Sunny Optical Technology (Group) Company Limited (SNPTF) Price Targets
| Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
|---|---|---|---|
| $N/A | $N/A | $N/A | N/A% |
Price Target
Sunny Optical Technology (Group) Company Limited does not have any price target set by analysts.
Analyst Price Targets ()
Broker Rating
Sunny Optical Technology (Group) Company Limited currently has an average brokerage recommendation (ABR) of 1.67 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by three brokerage firms. The current ABR compares to an ABR of 3.00 a month ago based on three recommendations.
Of the three recommendations deriving the current ABR, two are Strong Buy, representing 66.67% of all recommendations. There was no Strong Buy or Buy recommendation a month ago.
Broker Rating Breakdown
Brokerage Recommendations
| Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 2 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| ABR | 1.67 | 2.33 | 3.00 | 3.00 | 3.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
| Date | Brokerage Firm | Analyst | Previous | Current |
|---|---|---|---|---|
| 6/19/2024 | CLSA Americas | Tony Zhang | Hold | Strong Buy |
| 3/31/2024 | Goldman Sachs | Allen Chang | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
| Current ABR | 1.67 |
| ABR (Last week) | 2.33 |
| # of Recs in ABR | 3 |
| Average Target Price | NA |
| LT Growth Rate | NA |
| Industry | Medical - Products |
| Industry Rank by ABR | 163 of 252 |
| Current Quarter EPS Est: | NA |